214 related articles for article (PubMed ID: 9704494)
1. Organizational changes in Canada.
Décary F
Vox Sang; 1998; 74 Suppl 2():527-9. PubMed ID: 9704494
[No Abstract] [Full Text] [Related]
2. Long-awaited Canadian blood report released.
Murray T
Nat Med; 1998 Jan; 4(1):10. PubMed ID: 9427591
[No Abstract] [Full Text] [Related]
3. Within the walls of Parliament: government decision-making around compensation for contaminated blood.
Faulkner DB
Health Law Can; 2005 May; 25(4):53-72. PubMed ID: 16053052
[No Abstract] [Full Text] [Related]
4. International views on universal leucodepletion: the perspective in Germany.
Seitz MD
Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
[No Abstract] [Full Text] [Related]
5. Risk management in blood transfusion services.
Whyte G
Vox Sang; 1998; 74 Suppl 2():105-9. PubMed ID: 9704431
[TBL] [Abstract][Full Text] [Related]
6. Former health secretary is still pushing for justice over contaminated blood scandal.
Rimmer A
BMJ; 2017 Sep; 358():j4113. PubMed ID: 28870980
[No Abstract] [Full Text] [Related]
7. Blood-bank testing for infectious diseases: how safe is blood transfusion?
Strong DM; Katz L
Trends Mol Med; 2002 Jul; 8(7):355-8. PubMed ID: 12114117
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Canadian blood system: the Krever Inquiry, Canadian Blood Services and Héma-Québec. Krever Commission.
Rock G
Transfus Sci; 2000; 22(1-2):29-37. PubMed ID: 10771376
[TBL] [Abstract][Full Text] [Related]
9. Contaminated blood.
Machin SJ
Med Leg J; 2004; 72(Pt 3):77-87. PubMed ID: 15524115
[No Abstract] [Full Text] [Related]
10. [Transfusion safety].
Aprili G
Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
[No Abstract] [Full Text] [Related]
11. Is the gift still good? Examining the politics and regulation of blood safety in the European Union.
Farrell AM
Med Law Rev; 2006; 14(2):155-79. PubMed ID: 16831820
[No Abstract] [Full Text] [Related]
12. Final Krever report paints picture of regulatory dysfunction.
Kondro W
Lancet; 1997 Dec; 350(9092):1688. PubMed ID: 9400528
[No Abstract] [Full Text] [Related]
13. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
Busch MP
Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
[No Abstract] [Full Text] [Related]
14. Oversight and monitoring of blood safety in the United States.
Busch M; Chamberland M; Epstein J; Kleinman S; Khabbaz R; Nemo G
Vox Sang; 1999; 77(2):67-76. PubMed ID: 10516550
[TBL] [Abstract][Full Text] [Related]
15. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
Sobel RK
US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
[No Abstract] [Full Text] [Related]
16. International views on universal leucodepletion: the perspective in NBS, Ireland.
Murphy W
Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
[No Abstract] [Full Text] [Related]
17. Blood & politics.
Titus K
CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
[No Abstract] [Full Text] [Related]
18. [National French Blood Agency].
Rev Infirm; 2003 Jan; (87):27-8. PubMed ID: 12677901
[No Abstract] [Full Text] [Related]
19. Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply.
Rueda A
J Health Law; 2001; 34(3):419-58. PubMed ID: 11571894
[TBL] [Abstract][Full Text] [Related]
20. Haemovigilance: concept, Europe and UK initiatives.
McClelland B; Love E; Scott S; Williamson LM
Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
